A clinical formulation indicated for Women's Health and Oncology Support. This treatment functions as a selective estrogen receptor modulator to support hormonal regulation and cellular health.
A hormonal therapy agent formulated to manage breast cancer risk and designed to alleviate tumor progression by targeting estrogen receptors in breast tissue.
Mechanism of Action
It competitively binds to estrogen receptors on breast cancer cells. This blocks the growth-promoting effects of estrogen, slowing the cancer.
Route of Administration
Oral
Onset Time
Weeks (full effect)
Duration
24 hours
Contraindications
Pregnancy, History of DVT or PE (prevention only), Concurrent warfarin use (prevention only)
Severe Adverse Events
Uterine cancer risk, Blood clots (DVT/Stroke), Liver damage, Cataracts
Common Side Effects
Hot flashes, Vaginal discharge
Uncommon Side Effects
Irregular periods, Nausea, Weight gain, Fluid retention, Vaginal dryness
Information for Tamoxifen is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
